TD Cowen analyst Ryan Langston has maintained their bullish stance on ELV stock, giving a Buy rating on January 24.Invest with Confidence: ...
After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...
Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly ...
Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.
Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.
Elevance Health Inc.’s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...